Raquel
Marzoa Rivas
Raquel Marzoa Rivas-rekin lankidetzan egindako argitalpenak (7)
2020
-
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 22, Núm. 8, pp. 1424-1437
-
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 22, Núm. 1, pp. 92-102
-
Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 22, Núm. 8, pp. 1378-1389
2019
-
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1338-1352
-
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397
2018
-
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry
JACC: Heart Failure, Vol. 6, Núm. 6, pp. 452-462
2013
-
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 15, Núm. 10, pp. 1173-1184